Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Shares Outstanding (Weighted Average) (2016 - 2025)

Medifast's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $11.0 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.47% year-over-year to $11.0 million; the TTM value through Dec 2025 reached $11.0 million, changed 0.47%, while the annual FY2025 figure was $11.0 million, 0.47% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $11.0 million in Q4 2025 per MED's latest filing, roughly flat from $11.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.8 million in Q1 2021 to a low of $10.9 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $11.2 million, with a median of $11.0 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): decreased 6.6% in 2022, then increased 0.56% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $11.7 million in 2021, then decreased by 4.36% to $11.2 million in 2022, then dropped by 2.78% to $10.9 million in 2023, then grew by 0.42% to $10.9 million in 2024, then increased by 0.47% to $11.0 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Shares Outstanding (Weighted Average) are $11.0 million (Q4 2025), $11.0 million (Q3 2025), and $11.0 million (Q2 2025).